Dr. Marschall S. Runge Elected to Lilly Board of Directors

PR Newswire/Les Echos/ 
Dr. Marschall S. Runge Elected to Lilly Board of Directors 
INDIANAPOLIS, Aug. 28, 2013 -- The Board of Directors of Eli Lilly and Company
(NYSE: LLY) has elected Marschall S. Runge, M.D., Ph.D., as a new member,
effective September 1, 2013. Dr. Runge, 59, is the Executive Dean for the 
School of Medicine at the University of North Carolina at Chapel Hill (UNC). 
As a member of Lilly's board, Dr. Runge will serve on the Science and 
Technology Committee and the Public Policy and Compliance Committee. 
"I am very pleased to welcome Marschall Runge to the Lilly board," said John
Lechleiter, Ph.D., Lilly chairman, president and chief executive officer. "Dr.
Runge brings to the Lilly board a broad background in health care, with
extensive experience as a practicing physician, clinical researcher, and dean 
of a major academic medical institution. His appreciation of the importance of
scientific research, coupled with his first-hand experience in patient care,
will help Lilly deliver on its commitment to discover and develop innovative
medicines that make a difference for patients in need." 
In his role as Executive Dean for the UNC School of Medicine, Dr. Runge 
provides overall academic and clinical leadership for the School of Medicine 
and the UNC Health Care System. In addition to being the Chair of the 
Department of Medicine, Dr. Runge is also Principal Investigator and Director 
of the North Carolina Translational and Clinical Sciences (NC TraCS) Institute 
at UNC-Chapel Hill, where he has financial, human resource and strategic 
oversight responsibilities for the program. The NC TraCS Institute is one of 
60 medical research institutions working together as part of a national 
consortium to improve the way biomedical research is conducted across the 
country and to reduce the time it takes for laboratory discoveries to become 
new treatments for patients. 
An honors graduate of Vanderbilt University with a B.A. in Biology and a Ph.D.
in molecular biology, Dr. Runge earned his M.D. from the Johns Hopkins School 
of Medicine, where he was an intern and resident in internal medicine. He then
completed a cardiology fellowship at Harvard's Massachusetts General Hospital
and was a faculty member there prior to moving to Emory University as an
Associate Professor of Medicine in 1989. Before joining the UNC faculty in 
2000, Dr. Runge held the John Sealy Distinguished Centennial Chair in Internal
Medicine and was Director of the Division of Cardiology and the Sealy Center 
for Molecular Cardiology at the University of Texas Medical Branch at 
Galveston. 
In addition to serving as a member of the Experimental Cardiovascular Sciences
Study Section of the National Institutes of Health, Dr. Runge also has 
published over 150 peer-reviewed manuscripts and is a renowned leader in 
vascular biology. 
About Lilly
Lilly, a leading innovation-driven corporation, is developing a growing
portfolio of pharmaceutical products by applying the latest research from its
own worldwide laboratories and from collaborations with eminent scientific
organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -
through medicines and information - for some of the world's most urgent medical
needs. Additional information about Lilly is available at www.lilly.com. C-LLY 
Refer to: (317) 433-9899 - Edward Sagebiel 
(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )
 

SOURCE Eli Lilly and Company 
                  
The content and accuracy of news releases published on this site and/or 
distributed by PR Newswire or its partners are the sole responsibility of the 
originating company or organisation. Whilst every effort is made to ensure the 
accuracy of our services, such releases are not actively monitored or reviewed 
by PR Newswire or its partners and under no circumstances shall PR Newswire or 
its partners be liable for any loss or damage resulting from the use of such 
information. All information should be checked prior to publication. 
-0- Aug/28/2013 14:52 GMT
 
 
Press spacebar to pause and continue. Press esc to stop.